Drug Repurposing for the Treatment of Childhood Leukemia

Treatment-related toxicities from conventional chemotherapy can cause suffering in many patients with childhood leukemia. The search continues for medications that are effective while producing fewer adverse effects. Pediatric hematologist/oncologist, Seth Corey, MD, MPH, explains his latest study repurposing the antimalarial drug, mefloquine.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Advertising Policy

Outcomes of Unilateral Cataract Surgery in Infants and Toddlers With Aphakia and Pseudophakia

Complications for infants undergoing implantation of intraocular lenses (IOL) include the need for additional surgery and other adverse events, such as pupillary membrane and corectopia. A new study of the effects of age on outcomes of cataract surgery finds fewer adverse effects from IOL in children between the ages of 7 – 24 months, compared to children under 7 months.